These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 18372122)

  • 1. New ways to identify novel bacterial antigens for vaccine development.
    Movahedi AR; Hampson DJ
    Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-derived vaccines.
    De Groot AS; Rappuoli R
    Expert Rev Vaccines; 2004 Feb; 3(1):59-76. PubMed ID: 14761244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics approaches towards antigen discovery and vaccine development.
    Klade CS
    Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
    Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
    J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens.
    Meinke A; Henics T; Hanner M; Minh DB; Nagy E
    Vaccine; 2005 Mar; 23(17-18):2035-41. PubMed ID: 15755567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antigenome technology: rapid and comprehensive identification and validation of antigens as putative components in vaccines against bacterial pathogens].
    Henics T; Nagy E
    Orv Hetil; 2005 Oct; 146(43):2209-14. PubMed ID: 16323567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmonella-based vaccines for infectious diseases.
    Kwon YM; Cox MM; Calhoun LN
    Expert Rev Vaccines; 2007 Apr; 6(2):147-52. PubMed ID: 17408365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics: how it is being used to identify bacterial vaccine candidates.
    Zagursky RJ; Olmsted SB; Russell DP; Wooters JL
    Expert Rev Vaccines; 2003 Jun; 2(3):417-36. PubMed ID: 12903807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach.
    Mora M; Donati C; Medini D; Covacci A; Rappuoli R
    Curr Opin Microbiol; 2006 Oct; 9(5):532-6. PubMed ID: 16890009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
    Seib KL; Zhao X; Rappuoli R
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial genomics and vaccine design.
    Sampson SL; Rengarajan J; Rubin EJ
    Expert Rev Vaccines; 2003 Jun; 2(3):437-45. PubMed ID: 12903808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-based approaches to develop vaccines against bacterial pathogens.
    Serruto D; Serino L; Masignani V; Pizza M
    Vaccine; 2009 May; 27(25-26):3245-50. PubMed ID: 19200820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines against intracellular bacterial pathogens.
    Titball RW
    Drug Discov Today; 2008 Jul; 13(13-14):596-600. PubMed ID: 18598915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of genomics on vaccine design.
    Scarselli M; Giuliani MM; Adu-Bobie J; Pizza M; Rappuoli R
    Trends Biotechnol; 2005 Feb; 23(2):84-91. PubMed ID: 15661345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of genomics in bacterial vaccine discovery: a decade in review.
    Zagursky RJ; Anderson AS
    Curr Opin Pharmacol; 2008 Oct; 8(5):632-8. PubMed ID: 18625342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse vaccinology and genomics.
    Rappuoli R; Covacci A
    Science; 2003 Oct; 302(5645):602. PubMed ID: 14576423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-based vaccine development: a short cut for the future.
    Moriel DG; Scarselli M; Serino L; Mora M; Rappuoli R; Masignani V
    Hum Vaccin; 2008; 4(3):184-8. PubMed ID: 20686357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach.
    Li H; Xiong XP; Peng B; Xu CX; Ye MZ; Yang TC; Wang SY; Peng XX
    J Proteome Res; 2009 Sep; 8(9):4342-9. PubMed ID: 19640004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial infectious disease control by vaccine development.
    Curtiss R
    J Clin Invest; 2002 Oct; 110(8):1061-6. PubMed ID: 12393839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.